Credit Suisse’s HI-TECH PHARMACAL INC HITK Stock Holding History

Credit Suisse’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6,628	Closed	-$287K	–	4992
2014 Q1	$287K	Sell	6,628 -943	-12%	-$40.9K	﹤0.01%	4140
2013 Q4	$328K	Sell	7,571 -2,973	-28%	-$128K	﹤0.01%	4018
2013 Q3	$455K	Sell	10,544 -2,025	-16%	-$77.5K	﹤0.01%	3551
2013 Q2	$418K	Buy	+12,569	New	+$418K	﹤0.01%	3422

Credit Suisse's HITK Position: Q2 2014 in Review

Credit Suisse sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 6,628 shares — an estimated $287K sold.

Credit Suisse first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $455K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Credit Suisse reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Credit Suisse sold 6,628 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $287K.
Credit Suisse first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Credit Suisse's HI-TECH PHARMACAL INC position peaked at $455K in Q3 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.